SECFilings.com

Recent News

  • FDA Approves Landmark COVID/Heart/CBD Clinical Trial -- SECFilings.com

    Redondo Beach, California--(Newsfile Corp. - September 30, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering a potentially major development in the quest to improve outcomes for COVID-19 patients. The US Food and Drug Administration (FDA) recently approved an Investigational New Drug application by Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) that opens the door for Cardiol to conduct its Phase II/III trial. The...

    2020-09-30 9:00 AM EDT
  • Battery Day: Still Plenty of Headroom for Lesser-Known Electric Vehicle/Battery Stocks -- SECFilings.com

    Redondo Beach, California--(Newsfile Corp. - September 22, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article discussing the electric vehicle and lithium-ion battery sectors. Ahead of Tesla's Battery Day, a major event in the electric vehicle and electric battery space, it might be worth noting a couple of trends. First, the sector has shown explosive growth recently, led by major companies like Tesla, Nikola...

    2020-09-22 2:42 PM EDT
  • Cannabidiol Phase 1 Clinical Trial Launches, Targeting Inflammatory Heart Condition -- SECFilings.com

    Redondo Beach, California--(Newsfile Corp. - September 16, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering Cardiol Therapeutics Inc.'s (TSX: CRDL) (OTCQX: CRTPF) initiation of a Phase 1 clinical study, intended to assess the safety, tolerability, and pharmacokinetics of its proprietary cannabidiol (CBD) formulation, CardiolRx™. The results of this study will inform Cardiol's planned Phase 2 international trial of CardiolRx™ for the treatment...

    2020-09-16 9:01 AM EDT
  • Orphan Drug Designation Is Proven Path for CBD -- SECFilings.com

    Redondo Beach, California--(Newsfile Corp. - August 5, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article discussing how the past success of the orphan drug designation informs Cardiol Therapeutics Inc.'s (TSX: CRDL) (OTCQX: CRTPF) effort to develop CBD as a treatment for acute myocarditis. The Canadian-based company is utilizing pharmaceutical CBD in its research programs focused on various forms of heart failure and is preparing...

    2020-08-05 9:00 AM EDT
  • Heart Health and COVID-19: Fighting Inflammation May be Key -- SECFilings.com

    Redondo Beach, California--(Newsfile Corp. - July 15, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article discussing the connection between heart disease, COVID-19, and inflammation. Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF), a pharmaceutical development company focused on heart health, is developing therapies to address the intertwined effects of these three conditions with the hope of improving outcomes for COVID-19 patients.It is no secret that...

    2020-07-15 9:00 AM EDT
  • LexaGene CEO Discusses COVID-19 Testing, Commercialization Strategy -- SECFilings.com

    Redondo Beach, California--(Newsfile Corp. - April 16, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an interview with Dr. Jack Regan, CEO and Founder of LexaGene Holdings Inc. (OTCQB: LXXGF) (TSX-V: LXG), discussing the company's development of genetic analyzers capable of quickly and accurately detecting pathogens, including COVID-19. Dr. Regan has an extensive background in virology, and particularly respiratory pathogens and bio-threat agents. In the interview,...

    2020-04-16 9:00 AM EDT
  • Cannabis Businesses Essential in Stressful Times -- SECFilings.com

    Redondo Beach, California--(Newsfile Corp. - April 13, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article discussing the robust level of cannabis sales during the ongoing pandemic response and the role of companies like Digipath, Inc. (OTCQB: DIGP) in supporting the industry while consumer brands find their footing.If you've been following the cannabis industry, and particularly the investment climate around that industry, at all...

    2020-04-13 3:25 PM EDT
  • Coronavirus Highlights Need for Rapid Testing of Pathogens -- SECFilings.com

    Seattle, Washington--(Newsfile Corp. - March 9, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article discussing how LexaGene Holdings Inc. (OTCQB: LXXGF) (TSXV: LXG) is focused on making testing for pathogens quicker and easier than ever before.A California woman was identified, on February 26, 2020, as the first U.S. resident to contract the coronavirus (COVID-19) from an unknown source. All other cases to that point...

    2020-03-09 7:00 AM EDT